| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |